Research
FORUM TRANSCRIPT

Robotic-assisted Knee Reconstruction Surgery – Competitive Landscape & Adoption Dynamics

  • Public Equity
  • Healthcare
  • North America
PREMIUM

Specialist

Senior director at Smith & Nephew plc

Agenda

  • Key drivers behind continued adoption of robotic-assisted knee reconstruction surgery, including clinical benefits and patient satisfaction
  • Competitive dynamics across key players including Zimmer Biomet's (NYSE: ZBH) Rosa, Johnson & Johnson's (NYSE: JNJ) Velys and Stryker's (NYSE: SYK) Mako
  • Shift in commercial agreements including volume commitments and benefits to tier 2 players

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo